Long-term evaluation of postoperative acromegalic patients in remission with previous and newly proposed criteria

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 3, 2005, Pages 1377-1382

  Ronchi, Cristina L ^a   Varca, Virginia ^a   Giavoli, Claudia ^a   Epaminonda, Paolo ^b   Beck Peccoz, Paolo ^a   Spada, Anna ^a   Arosio, Maura ^a,b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN; HUMAN GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; FOLLOW UP; HORMONE RESPONSE; HUMAN; MALE; ORAL GLUCOSE TOLERANCE TEST; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; REMISSION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; BLOOD; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED; TIME;

ACROMEGALY; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; REMISSION INDUCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 15944389879     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-1974     Document Type: Article

References (38)

1. Growth Hormone Research Society: Pituitary Society 2004 Biochemical assessment and long-term monitoring in patients with acromegaly: statement from a joint consensus conference of the Growth Hormone Research Society and the Pituitary Society. J Clin Endocrinol Metab 89:3099-3102
2. Barkan AL 2004 Jun biochemical markers of acromegaly: GH vs. IGF-I. Growth Horm IGF Res 14(Suppl A):S97-S100
3. Lindholm J, Giwercman B, Giwercman A, Astrup J, Bjerre F, Skakkebaek NE 1987 Investigation of the criteria for assessing the outcome of treatment in acromegaly. Clin Endocrinol (Oxf) 27:553-562
4. Bates AS, Van'T Hoff W, Jones JM, Clayton RN 1993 An audit of outcome of treatment in acromegalv. Q J Med 79:70-75
5. Sheaves R, Jenkins P, Blackburn P, Huneidi AH, Afshar F, Medbak S, Grossman AB, Besser GM, Wass JA 1996 Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure. Clin Endocrinol (Oxf) 45:407-413
6. Freda PU, Wardlaw SL, Post KD 1998 Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly. J Neurosurg 89:353-358
7. Attanasio R, Oppizzi G, Lodrini S, Dallabonzana D, Batausse M, Orlandi P, DaRe N, Cozzi R 1999 Neurosurgery restores late GH rise after glucose-induced suppression in cured acromegalics. Eur J Endocrinol 140:23-28
8. Arosio M, Giovanelli MA, Riva E, Nava C, Ambrosi B, Faglia G 1983 Clinical use of pre- and postsurgical evaluation of abnormal GH responses in acromegaly. J Neurosurg 59:402-408
9. Brockmeier SJ, Buchfelder M, Fahlbusch R 1993 TRH/GnRH test in acromegaly. Long-term follow-up experience with successfully treated patients. Horm Metab Res 25:275-277
10. Biermasz NR, Smit JW, van Dulken H, Roelfsema F 2002 Postoperative persistent thyrotrophin releasing hormone-induced growth hormone release predicts recurrence in patients with acromegaly. Clin Endocrinol (Oxf) 56:313-319
11. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S 2000 Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85:526-529
12. Melmed S, Casanueva FF, Cavagnini F, Chanson P, Frohman L, Grossman A, Ho K, Kleinberg D, Lamberts S, Laws E, Lombardi G, Vance ML, Werder KV, Wass J, Giustina A: Acromegaly Treatment Consensus Workshop Participants 2002 Guidelines for acromegaly management. J Clin Endocrinol Metab 87:4054-4058
13. Freda PU, Post KD, Powell JS, Wardlaw SL 1998 Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly. J Clin Endocrinol Metab 83:3808-3816
14. Freda PU 2003 Current concepts in the biochemical assessment of the patient with acromegaly. Growth Horm IGF Res 13:171-184
15. Serri O, Beauregaid C, Hardy J 2004 Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly. J Clin Endocrinol Metab 89:658-661
16. Gullu S, Keles H, Delibasi T, Tonyukuk V, Kamel N, Erdogan G 2004 Remission criteria for the follow-up of patients with acromegaly. Eur J Endocrinol 150:465-471
17. Freda PU, Nuruzzaman AT, Reyes CM, Sundeen RE, Post KD 2004 Significance of "abnormal" nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels. J Clin Endocrinol Metab 89:495-500
18. Costa ACF, Rossi A, Martinelli CE, Machado HR, Moreira AC 2002 Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure? J Clin Endocrinol Metab 87:3142-3147
19. Minniti G, Jaffrain-Rea ML, Esposito V, Santoro A, Tamburano G, Cantore G 2003 Evolving criteria for post-operative biochemical remission of acromegaly: can we achieve a definitive cure? An audit of surgical results on a large series and a review of the literature. Endocr Relat Cancer 10:611-619
20. Takahashi JA, Shimatsu A, Nakao K, Hashimoto N 2004 Early postoperative indicators of late outcome in acromegalic patients. Clin Endocrinol (Oxf) 60:366-374
21. De Marinis L, Mancini A, Bianchi A, Gentilella R, Valle D, Giampietro A, Zuppi P, Anile C, Maira G, Giustina A 2002 Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients. Metabolism 51:616-621
22. Arosio M, Sartore G, Rossi CM, Casati G, Faglia G, Manzato E 2000 LDL physical properties, lipoprotein and Lp(a) levels in acromegalic patients. Effects of octreotide therapy. Italian Multicenter Octreotide Study Group. Atherosclerosis 151:551-557
23. Ronchi CL, Orsi E, Giavoli C, Cappiello V, Epaminonda P, Beck-Peccoz P, Arosio M 2003 Evaluation of insulin resistance in acromegalic patients before and after treatment with somatostatin analogues. J Endocrinol Invest 26:533-538
24. Epaminonda P, Porretti S, Cappiello V, Faglia G, Arosio M 2001 Efficacy of radiotherapy in normalizing serum IGF-I, acid-labile subunit (ALS) and IGF-BP3 levels in acromegaly. Clin Endocrinol (Oxf) 55:183-189
25. Dimaraki EV, Jaffe CA, DeMott-Friberg R, Chandler WF, Barkan AL 2002 Acromegaly with apparently normal GH secretion: implication for diagnosis and follow up. J Clin Endocrinol Metab 87:3537-3542
26. Kreutzer J, Vance ML, Lopes MB, Laws Jr ER 2001 Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. J Clin Endocrinol Metab 86:4072-4077
27. Ayuk J, Clayton RN, Holder G, Sheppard MC, Stewart PM, Bates AS 2004 Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. J Clin Endocrinol Metab 89:1613-1617
28. Swearingen B, Barker 2nd FG, Katznelson L, Biller BM, Grinspoon S, Klibanski A, Moayeri N, Black PM, Zervas NT 1998 Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 83:3419-3426
29. Holdaway IM, Rajasoorya RC, Gamble GD 2004 Factors influencing mortality in acromegaly. J Clin Endocrinol Metab 89:667-674
30. Biermasz NR, Dekker FW, Pereira AM, van Thiel SW, Schutte PJ, van Dulken H, Romijn JA, Roelfsema F 2004 Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements. J Clin Endocrinol Metab 89:2789-2796
31. Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ, Ibbertson HK 1994 Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf) 41:95-102
32. Holdaway IM, Rajasoorya CR, Gamble GD, Stewart AW 2003 Long-term treatment outcome in acromegaly. Growth Horm IGF Res 13:185-192
33. Arita K, Kurisu K, Tominaga A, Eguchi K, Iida K, Uozumi T, Kasagi F 2003 Mortality in 154 surgically treated patients with acromegaly-a 10-year follow-up survey. Endocr J 50:163-172
34. Valdemarsson S, Ljunggren S, Bramnert M, Norrhamn O, Nordstrom CH 2000 Early postoperative growth hormone levels: high predictive value for long-term outcome after surgery for acromegaly. J Intern Med 247:640-650
35. Roth J, Glick SM, Yalow RS, Berson SA 1963 Secretion of human GH: physiologic and experimental modifications. Metabolism 12:577
36. Masuda A, Shibasaki T, Nakahara M, Imaki T, Kiyosawa Y, Jibiki K, Demuia H, Shizume K, Ling N 1985 The effect of glucose on growth hormone (GH)-releasing hormone-mediated GH secretion in man. J Clin Endocrinol Metab 60:523-526
37. Mancini A, Zuppi P, Fiumara C, Valle D, Conte G, Fabrizi ML, Sammartano L, Anile C, Maira G, De Marinis L 1995 GH response to oral and intravenous glucose load in acromegalic patients. Horm Metab Res 27:322-325
38. Vierhapper H, Heinze G, Gessi A, Exner M, Bieglmayr C 2003 Use of the glucose tolerance test to define remission in acromegaly. Metabolism 52:181-185